Blog - Page 3663 of 5624

WednesdayAug 25, 2010 1:49 pm

PROLOR Biotech, Inc. (PBTH) Cleared by FDA for US Phase II HGH Trials

PROLOR, www.prolor-biotech.com – the biopharma firm utilizing a proprietary CTP technology to commercialize longer-acting, biologically improved versions of existing/approved therapeutics, reported receiving FDA regulatory clearance yesterday for Phase II clinical trials of hGH-CTP, the Company’s improved and longer-acting human growth hormone. The CTP technology allows PBTH to isolate short, naturally occurring amino acid sequences and develop them into cheaper, safer, easier to implement and more effective human growth hormones. FDA approval follows fast on the heels of PBTH’s submission of an investigational new drug application for hGH-CTP, which contained extensive preclinical and Phase I data, in addition to proposed pre-Phase…

WednesdayAug 25, 2010 12:41 pm

Brown Shoe Company, Inc. (BWS) Reports Increase in Second Quarter Earnings and Revenues

Brown Shoe Company, Inc. reported a double-digit percentage increase in revenues on a year over year basis in the second quarter of 2010. The company also reported a strong profit in the most recent quarter compared to a net loss a year earlier. Brown Shoe Company, Inc. reported revenues of $585.8 million in the second quarter of 2010, compared to $511.6 million in the same quarter of 2009. The company also reported net income of $5.3 million, or $0.12 per diluted share, compared to a net loss of $4.2 million, or ($0.10) per diluted share in the corresponding quarter of…

WednesdayAug 25, 2010 12:34 pm

Taylor Devices, Inc. (TAYD) Reports Fourth Quarter Fiscal 2010 Earnings

Taylor Devices, Inc. (TAYD) reported an increase in revenues and earnings for the fourth fiscal quarter of fiscal 2010, which ended May 31, 2010. Revenues totaled $4.6 million in the fourth quarter of fiscal 2010, up slightly from the $4.5 million in revenues reported for the fourth quarter of fiscal 2009. Taylor Devices, Inc. reported net income of $0.44 million, or $0.13 per diluted share, in the most recent quarter, up from net income of $0.34 million, or $0.10 per diluted share, in the corresponding quarter of the previous fiscal year. The management of Taylor Devices, Inc. noted strength in…

WednesdayAug 25, 2010 12:17 pm

Check Out QualityStocks New Video Player!

We're at it again! The new video player for our daily stock charts is just another way we're making the website even easier to use with better functionality and more features. Now you can adjust the volume, go full screen, and use built-in functionality to share the video with your friends via Email, FaceBook, Twitter or even grab the embed code for your own blog or website! Through each day's daily video chart, QualityStocks provide comprehensive coverage on the world of technical analysis. Technical analysis is the use of charts to provide another dimension to market analysis. Whether you're a user…

WednesdayAug 25, 2010 11:35 am

Balqon Corp. (BLQN.OB) Secures Partnership with DynaProTech for Zero-Emissions Drive Systems in China

Balqon Corp. develops and manufactures zero emissions, heavy-duty electric vehicles and drive systems. The company today announced it has received a $490,000 purchase order from DynaProTech, a leading composite automotive parts manufacturer in the People's Republic of China. Per the agreement, DynaProTech will integrate Balqon's zero-emissions electric drive systems into electric buses, heavy-duty trucks, light commercial vehicles and automobiles in China. Additionally, DynaProTech will provide servicing and parts for Balqon's products. Balwinder Samra, president and CEO of Balqon, said the agreement symbolizes Balqon’s broader mission to introduce its technologies to various international markets. "Our relationship with DynaProTech is a continuation…

WednesdayAug 25, 2010 10:37 am

National Automation Services, Inc. (NASV.PK) Takes The High Road

Unlike far too many companies, National Automation Services has taken the initiative to establish in writing a code of conduct well beyond the typical employee handbook “don’t steal paperclips” rules and restrictions. It recognizes and deals up front with many of the foundational weaknesses that seem to have colored corporate America in recent decades, as well as focusing as much on executives as it does on staff. Evidence of its intent is made clear by Mark Twain’s famous quotation displayed at the very top: “Always do right – this will gratify some, and astonish the rest.” Take a look at…

WednesdayAug 25, 2010 10:29 am

Neuralstem, Inc. (CUR) Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial

Neuralstem Inc. has patented technology which enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities. The company today announced that it has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This Phase I safety trial will enroll a total of 16 long-term spinal cord injury patients that have complete paralysis. The proposed trial is primarily designed to test the safety of both Neuralstem's cells and…

WednesdayAug 25, 2010 10:12 am

CHDT Corp. (CHDO.OB) Subsidiary Generating Revenues through Second Order from National Book Retailer

CHDT Corp. announced today that its wholly-owned subsidiary, Capstone Industries, has received a re-order from a national specialty book store chain. The book store chain has placed an additional order for Pathway Lights®, Multi-Pose Brightbook in two colors and the Retro Taskbright in two colors. The Multi-Pose Brightbook is a portable, lightweight and adjustable super-bright reading light that can either clip to the book or stand on its own. The contemporary design features 4 LED lights that never have to be replaced. The Retro Taskbright is similar in lighting capacity to the Bookbright, but has an on/off button and a…

WednesdayAug 25, 2010 10:09 am

Prana Biotechnology (PRAN) Secures European and U.S. Patents for Pharmaceutical Compounds

Prana Biotechnology was established to commercialize research into Alzheimer’s disease and other major age-related neurodegenerative disorders. In line with this objective, the company yesterday announced it has received key PBT2 patents in Europe and the United States for select pharmaceutical compositions. “The grant and extension of PBT2 patent rights in the United States together with securing European patent rights marks a critical milestone in our commercialization plans, offering opportunity in both Huntington’s disease and Alzheimer’s disease,” Geoffrey Kempler, Prana’s executive chairman stated in the press release. The U.S. Patent and Trademark Office (USPTO) granted Prana a composition of matter patent…

WednesdayAug 25, 2010 9:52 am

LECG Corporation (XPRT) Video Chart for Wednesday, August 25, 2010

XPRT has been on a massive slide for the last couple months. A support level at $1.25 is being established as the indicators give hints of a possible bounce or reversal. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

Site Search

Company Search